MOZOBIL (plerixafor) Patient Assistance Program
Don’t let the cost of darunavir disrupt your HIV treatment. Between generic darunavir at coupon prices near $61 a month, the J&J Patient Assistance Program, the $0 withMe card, and the Ryan White/ADAP safety net, an affordable route exists for nearly everyone. We find yours and manage it for a flat $69.95 per month.
- Clear & Transparent Pricing — Applying To J&J Directly Is Always Free
- Paperwork, Documentation & Doctor-Coordination Handled For You
- One-Time-Treatment Cost Planning — This Drug Bills Differently Than Monthly Medications
- Annual Re-certification And Refills Management
- Medicare Part B Guidance — Clinic-Administered Injections Follow Medical-Benefit Math
HIPAA Compliant
BBB Accredited
Secure Website
Key Takeaways:
- Mozobil (Plerixafor) Is A Stem-Cell Mobilizer Used Before Autologous Transplant In Multiple Myeloma And Non-Hodgkin Lymphoma — Daily Injections For Up To Four Days That Flush Stem Cells Into The Bloodstream So Collection (Apheresis) Can Succeed.
- Brand Runs About $9,745 Per 24 mg Vial — And A Mobilization Course Can Use Several Vials. Generic Plerixafor, Marketed Since 2023 By Multiple Manufacturers, Runs Roughly $344–$1,016 Per Vial: 90–96% Less For The Identical Drug.
- Sanofi Patient Connection Provides Free Medication To Patients With Household Income Up To 400% Of The Federal Poverty Level ($63,840 Single / $132,000 Family Of Four) — Uninsured And Qualifying Medicare Patients Included.
- The Billing Reality Most Families Never See Coming: Plerixafor Is Administered At The Transplant Center And Bills Under The Medical Benefit — Medicare Part B, Where 2026 Payment Runs About $684 Per Vial Post-Generic — Often Folded Into The Transplant Episode. Which Product The Center Stocks, And How It Bills, Decides Your Share.
What Is Mozobil Prescription Assistance Program?
The Mozobil Patient Assistance Program is run through Sanofi Patient Connection (1-888-847-4877, Mon–Fri 9 AM–8 PM ET), which provides free medication to qualifying patients: U.S. residents with household income up to 400% of the Federal Poverty Level who are uninsured or functionally uninsured, with a dedicated pathway for qualifying Medicare patients. But plerixafor is unlike every monthly drug on this site: it’s used once, intensively — daily clinic injections for up to four days before stem-cell collection — and it’s bought and billed by the transplant center, not picked up at a pharmacy. That changes everything about the cost conversation: generic plerixafor (marketed since 2023) has collapsed the price ~90–96%, Medicare Part B now reimburses around $684 per vial, and whether your family owes hundreds or thousands depends mostly on which product your center stocks, how the episode is billed, and what your medical-benefit cost-sharing looks like — questions worth asking before mobilization week, not after the bill. For a flat $69.95 per month, our Patient Advocates work those questions with your transplant center’s financial coordinators, file the Sanofi paperwork where it applies, and pursue foundation grants (HealthWell, PAF Co-Pay Relief myeloma funds) that cover transplant-related cost-sharing.
Pharmacy Price Comparison
- Without assistance, Mozobil costs roughly $9,000–$12,000 per single dose vial. A Patient Assistance Program is the meaningful path forward — if you qualify:
| Pharmacy(With Coupon) | PrIce (30-Day)* | You Save W/ Us |
|---|---|---|
| Walgreens | ~$11,500/dose | Save substantially |
| CVS Pharmacy | ~$12,000/dose | Save substantially |
| Walmart | ~$9,500/dose | Save substantially |
| Costco | ~$9,200/dose | Save substantially |
Specialty Pharmacy | ~$10,000/dose | Save substantially |
*Just a heads-up — retail prices are estimates based on public data and vary by pharmacy. AffordMyPrescriptions Advocacy Service bypasses this by using drug manufacturer programs to secure your medication directly at no cost or retail price.
Our Pricing:
$69.95 Per month
1 Medications
$79.95 Per Month
2 Medications
$89.95 Per Month
3 Medications
$99.95 Per Month
4+ Medications
Why choose us For Your Mozobil Prescription Program?
The Patient Assistance Program is free to apply for and provides Mozobil at no medication cost if approved. Our $69.95/month service covers full advocacy.
Enroll
Complete a simple eligibility form so our team can determine if you may qualify for medication assistance programs.
We Advocate
Our specialists help gather documentation, complete applications, and coordinate with program providers.
Receive Medication
Once approved, you may receive your medication through the assistance program while we help manage ongoing paperwork and renewals.
Discount Coupons vs. Patient Assistance Programs
Many patients try discount cards first. Here’s why the Patient Assistance Program through AffordMyPrescriptions is the better long-term solution for Mozobil:
Limitations of Coupons
- Prices fluctuate — savings aren’t guaranteed month-to-month
- Copay accumulators may prevent savings from counting toward deductible
- Coupon cards expire and require constant renewal
Still $9,000–$12,000 per dose per month even with the best discount
- Can’t be used with Medicare, Medicaid, or government insurance
Advantages of PAP Through Us
- Fixed $69.95/month — never changes regardless of retail price
- No expiration — continuous access as long as you qualify
- Medication supplied directly through the assistance program
- We manage all paperwork, refills, and annual renewals
- If denied, we explore alternative savings on your behalf
DO YOU QUALIFY?
Eligibility is generally determined by annual household income and insurance status. Most programs follow guidelines that include limits of up to $40,000 for individuals, $60,000 for couples, and $100,000 for larger families. Because requirements vary by program and household, we encourage you to contact AffordMyPrescriptions directly so we can review your specific situation and determine if you qualify for Mozobil assistance.
- You Are A U.S. Citizen Or Legal Resident
- You Have A Plerixafor (Mozobil) Order As Part Of A Stem-Cell Mobilization Plan
- You Are Uninsured, Functionally Uninsured, Or A Qualifying Medicare Patient
- Your Household Income Is At Or Below 400% Of The Federal Poverty Level — $63,840 (Single) Up To $132,000 (Family Of 4)
Not sure if you qualify? Our pre-qualification check is completely free. If we can’t help, you won’t be charged.
Understanding Mozobil:
Mozobil (plerixafor) is a stem-cell mobilizer — a targeted injection that releases blood-forming stem cells from the bone marrow into circulation, where they can be collected for an autologous transplant.
How Mozobil Works:
Stem cells anchor themselves in bone marrow via the CXCR4 receptor binding to its docking protein. Plerixafor blocks CXCR4, cutting the anchor line — within hours, stem cells flood the bloodstream. Given alongside G-CSF (filgrastim), it dramatically raises collection yields in multiple myeloma and non-Hodgkin lymphoma patients, including the “poor mobilizers” who would otherwise fail collection and lose their transplant window. That’s the stakes: this isn’t a maintenance drug but a gate — enough cells collected means the transplant proceeds.
Form and Use:
A subcutaneous injection given at the transplant center each evening for up to four consecutive days, roughly 11 hours before the next morning’s apheresis session, dosed by body weight. Because it’s clinician-administered in a facility, it lives entirely on the medical benefit — no pharmacy, no Part D, no coupon infrastructure — and its cost usually arrives inside the larger transplant-episode billing, which is where the questions should be asked.
Generic Availability:
Fully arrived: generic plerixafor has been marketed since August 2023 (Fresenius Kabi first, multiple manufacturers since), collapsing per-vial prices from ~$9,745 to roughly $344–$1,016 — and dragging Medicare’s Part B payment rate down to about $684 per vial by 2026. Most centers stock generic; confirming yours does is the single highest-value question a family can ask before mobilization.
Warnings:
Plerixafor commonly causes injection-site reactions, diarrhea, nausea, and dizziness during the brief treatment window. Rare but serious: splenic enlargement and rupture — report left-upper-abdominal or shoulder-tip pain immediately — and hypersensitivity reactions monitored post-injection. It can mobilize tumor cells in leukemia (not an approved use), and is used with caution in moderate-to-severe kidney impairment at reduced doses.
FAQ (Frequently Asked Questions)
How Much Does Mozobil Cost Without Insurance?
Brand lists around $9,745 per 24 mg vial, and a course may use several vials — but generic plerixafor runs $344–$1,016 per vial, and income-eligible patients can receive the drug free through Sanofi Patient Connection. Our $69.95 monthly fee covers the center-billing coordination that actually determines what a family pays.
Does Medicare Cover Mozobil?
Yes — under Part B as a clinic-administered injection, at a 2026 payment rate of roughly $684 per vial (post-generic), with 20% coinsurance that a supplement absorbs. The $2,100 Part D pharmacy cap doesn’t apply. For Medicare patients without supplements, foundation grants and the Sanofi program fill the gap.
Is There A Generic For Mozobil?
Yes — marketed since 2023 by multiple manufacturers at 90–96% below brand. Whether you get it depends on what your transplant center stocks, not on anything at a pharmacy counter — so ask, early, and we’ll ask with you.
Why Is There No Copay Card?
Clinic-administered oncology drugs rarely carry retail-style cards, and Sanofi’s CareASSIST doesn’t list Mozobil. The equivalents here are foundation funds — HealthWell and PAF Co-Pay Relief run multiple myeloma funds that cover exactly this kind of cost-sharing — plus hospital financial assistance, and we pursue all of them.
What If I’m A “Poor Mobilizer”?
That’s precisely who plerixafor exists for — patients whose counts don’t rise enough on G-CSF alone. Clinically it’s your transplant team’s call; financially it means the drug may be added on short notice mid-mobilization, which is why we set up the coverage questions before collection week rather than during it.
Does The Sanofi Program Cover Medicare Patients?
Sanofi Patient Connection has a dedicated Medicare pathway for qualifying patients within the income limits — with the caveat that Part D-covered situations get transitioned back to Part D each calendar year. Given plerixafor usually bills Part B anyway, the PAP’s main role is uninsured and coverage-gap cases; we sort which applies to you.
What If My Application Is Denied?
Denials are usually about documentation — income proof or insurance-status details. Applications can be corrected and resubmitted on transplant timelines, and foundation funds plus hospital assistance run as parallel paths. We review the denial letter, fix what triggered it, and resubmit immediately.
Take Control of Your Medication Costs
Mobilization happens once, on a schedule your transplant sets — the affordability work has to be done before that week arrives. Generic stock questions, Part B math, the Sanofi program, and myeloma foundation funds: we line them all up so collection day is about cells, not bills. Check your eligibility today; the pre-qualification review is free, and if we can’t help you, you pay nothing.
Submit Enrollment Form
Start free by filling out a simple online form.
Receive Welcome Call
Our specialist will contact you for a quick welcome call.
We Manage The Process
Our team handles everything, so you can focus on your health.